Form 8-K - Current report:
SEC Accession No. 0001493152-24-036212
Filing Date
2024-09-13
Accepted
2024-09-13 16:33:28
Documents
14
Period of Report
2024-09-09
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40381
  Complete submission text file 0001493152-24-036212.txt   218733

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nrxs-20240909.xsd EX-101.SCH 3015
3 XBRL LABEL FILE nrxs-20240909_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE nrxs-20240909_pre.xml EX-101.PRE 24165
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3790
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

EIN.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41775 | Film No.: 241298217
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 03 Life Sciences)